Anti-EGF receptor antibody (Cetuximab) was attached to IO-NPs and used to treat nude rats with H460 lung cancer xenografts with MRgFUS. Application of anti-EGFR-IO-NPs reduced energy for MRgFUS and led to smaller tumor sizes. Here, EGFR is linked to neoplasm.